Graft-Versus-Host Disease Prophylaxis with Posttransplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis

被引：0
|
作者：
Morozova, Elena V.
Moiseev, Ivan S.
Barabanshikova, Maria V.
Darskaya, Elena I.
Bondarenko, Sergey N.
Zubarovskaya, Ludmila S.
Baykov, Vadim
Alyanski, Alexandr L.
Barkhatov, Ildar M.
Zander, Axel R.
Afanasyev, Boris V.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4492
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Prophylaxis and treatment of acute graft-versus-host disease
    Chao, NJ
    Chen, BJ
    SEMINARS IN HEMATOLOGY, 2006, 43 (01) : 32 - 41
  • [22] Choosing a Regimen for Prophylaxis of Graft-versus-Host Disease
    Jong Wook Lee
    H. Joachim Deeg
    BioDrugs, 1997, 7 : 15 - 22
  • [23] Sitagliptin for Prophylaxis of Acute Graft-versus-Host Disease
    Cooper, Dennis L.
    Strair, Roger
    Jaschke, Nikolai P.
    Link-Rachner, Cornelia S.
    Rachner, Tilman D.
    Farag, Sherif S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (14): : 1374 - 1376
  • [24] Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis
    Ardizzoia, Federica
    Lorentino, Francesca
    Bruno, Alessandro
    Marktel, Sarah
    Giglio, Fabio
    Clerici, Daniela
    Farina, Francesca
    Mastaglio, Sara
    Piemontese, Simona
    Assanelli, Andrea A.
    Carrabba, Matteo G.
    Bernardi, Massimo
    Corti, Consuelo
    Peccatori, Jacopo
    Ciceri, Fabio
    Greco, Raffaella
    Lupo-Stanghellini, Maria Teresa
    HAEMATOLOGICA, 2022, 107 (11) : 2748 - 2751
  • [25] Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis
    Ardizzoia, Federica
    Lorentino, Francesca
    Bruno, Alessandro
    Marktel, Sarah
    Giglio, Fabio
    Clerici, Daniela
    Farina, Francesca
    Mastaglio, Sara
    Piemontese, Simona
    Assanelli, Andrea A.
    Carrabba, Matteo G.
    Bernardi, Massimo
    Corti, Consuelo
    Peccatori, Jacopo
    Ciceri, Fabio
    Greco, Raffaella
    Lupo-Stanghellini, Maria Teresa
    HAEMATOLOGICA, 2022, 107 : 2748 - 2751
  • [26] Choosing a regimen for prophylaxis of graft-versus-host disease
    Lee, JW
    Deeg, HJ
    BIODRUGS, 1997, 7 (01) : 15 - 22
  • [27] Treatment of Corticosteroid-Refractory Graft-Versus-Host Disease with Ruxolitinib in 95 Patients
    Zeiser, Robert
    Burchert, Andreas
    Lengerke, Claudia
    Verbeek, Mareike
    Maas-Bauer, Kristina
    Metzelder, Stephan
    Spoerl, Silvia
    Ditschkowski, Markus
    Ecsedi, Matyas
    Sockel, Katja
    Ayuk, Francis
    Ajib, Salem
    de Fontbrune, Flore Sicre
    Na, Il-Kang
    Penter, Livius
    Holtick, Udo
    Wolf, Dominik
    Schuler, Esther
    Meyer, Everett
    Apostolova, Petya
    Bertz, Hartmut
    Marks, Reinhard
    Luebbert, Michael
    Waesch, Ralph M.
    Scheid, Christof
    Stoelzel, Friedrich
    Ordemann, Rainer
    Bug, Cesine
    Kobbe, Guido
    Negrin, Robert
    Brune, Mats L.
    Spyridonidis, Alexandros
    Schmitt-Graeff, Annette
    van der Velden, Walter
    Huls, Gerwin
    Mielke, Stephan
    Grigoleit, Goetz Ulrich
    Kuball, Jurgen
    Flynn, Ryan P.
    Ihorst, Gabriele
    Du, Jing
    Blazar, Bruce R.
    Arnold, Renate
    Kroeger, Nicolaus
    Halter, Joerg
    Socie, Gerard
    Beelen, Dietrich
    Pesche, Christian, I
    Neubauer, Andreas
    Finke, Juergen
    BLOOD, 2015, 126 (23)
  • [28] Prophylaxis of graft-versus-host disease with cyclosporine–prednisone is associated with increased risk of chronic graft-versus-host disease
    S Kumar
    MG Chen
    DA Gastineau
    MA Gertz
    DJ Inwards
    MQ Lacy
    A Tefferi
    WS Harmsen
    MR Litzow
    Bone Marrow Transplantation, 2001, 27 : 1133 - 1140
  • [29] Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease
    Gozzo, Lucia
    Leotta, Salvatore
    Romano, Giovanni Luca
    Vetro, Calogero
    Duminuco, Andrea
    Milone, Giuseppe
    Cupri, Alessandra
    Palumbo, Fanny Erika
    Brancati, Serena
    Ruscica, Rosy
    Longo, Laura
    Vitale, Daniela Cristina
    Fiorenza, Giorgia
    Lombardo, Giovanni Enrico
    Lazzara, Antonio
    Di Raimondo, Francesco
    Palumbo, Giuseppe Alberto
    Drago, Filippo
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (14)
  • [30] Ruxolitinib during Peritransplant Period for Myelofibrosis Patients Undergoing Allogeneic Stem Cell Transplantation Reduces Acute Graft-Versus-Host Disease
    Kroger, Nicolaus
    Abd Kadir, Sharifah Shahnaz Syed
    Zabelina, Tatjana
    Wolschke, Christine
    Ayuk, Francis A.
    Badbaran, Anita
    Christopeit, Maximilian
    BLOOD, 2016, 128 (22)
12345